Could 18 F-DPA-714 PET imaging be interesting to use in the early post-stroke period?

EJNMMI Research

Volumn 4, Issue 1, 2014, Pages 1-8

  Ribeiro, Maria Joao ^a,b,c,f   Vercouillie, Johnny ^a   Debiais, Severine ^b   Cottier, Jean Philippe ^a,b   Bonnaud, Isabelle ^b   Camus, Vincent ^a,b,c   Banister, Samuel ^d,e   Kassiou, Michael ^d,e   Arlicot, Nicolas ^a,b   Guilloteau, Denis ^a,b,c  

^a UNIVERSITÉ DE TOURS   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

^c INSERM   (France)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f CHU BRETONNEAU   (France)

Author keywords

18 F DPA 714; Neuroinflammation; PET; Stroke

Indexed keywords

FLUORINE 18 DPA 714; RADIOISOTOPE; TRANSCRIPTION FACTOR; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; CEREBELLUM; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG BINDING; DRUG UPTAKE; FEMALE; HUMAN; MALE; MIDDLE CEREBRAL ARTERY; NERVOUS SYSTEM INFLAMMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOACTIVITY; VERY ELDERLY;

EID: 84902226309     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/s13550-014-0028-4     Document Type: Article

References (40)

1. Bikbov B, Perico N, Remuzzi G: Mortality landscape in the global burden of diseases, injuries and risk factors study.Eur J Intern Med 2014, 25:1–5.
2. Collaborators UBod: The state of US health, 1990–2010: burden of diseases, injuries, and risk factors.JAMA 2013, 310:591–608.
3. Donnan GA, Fisher M, Macleod M, Davis SM: Stroke.Lancet 2008, 371:1612–1623.
4. Lo EH, Dalkara T, Moskowitz MA: Mechanisms, challenges and opportunities in stroke.Nat Rev Neurosci 2003, 4:399–415.
5. Lai AY, Todd KG: Hypoxia-activated microglial mediators of neuronal survival are differentially regulated by tetracyclines.Glia 2006, 53:809–816.
6. Tymianski M: Novel approaches to neuroprotection trials in acute ischemic stroke.Stroke 2013, 44:2942–2950.
7. Deddens LH, Van Tilborg GA, Mulder WJ, De Vries HE, Dijkhuizen RM: Imaging neuroinflammation after stroke: current status of cellular and molecular MRI strategies.Cerebrovasc Dis 2012, 33:392–402.
8. Jacobs AH, Tavitian B: Noninvasive molecular imaging of neuroinflammation.J Cereb Blood Flow Metab 2012, 32:1393–1415.
9. Thiel A, Heiss WD: Imaging of microglia activation in stroke.Stroke 2011, 42:507–512.
10. del Zoppo GJ, Pessin MS, Mori E, Hacke W: Thrombolytic intervention in acute thrombotic and embolic stroke.Semin Neurol 1991, 11:368–384.
11. Mabuchi T, Kitagawa K, Ohtsuki T, Kuwabara K, Yagita Y, Yanagihara T, Hori M, Matsumoto M: Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats.Stroke 2000, 31:1735–1743.
12. Danton GH, Dietrich WD: Inflammatory mechanisms after ischemia and stroke.J Neuropathol Exp Neurol 2003, 62:127–136.
13. Rallidis LS, Vikelis M, Panagiotakos DB, Rizos I, Zolindaki MG, Kaliva K, Kremastinos DT: Inflammatory markers and in-hospital mortality in acute ischaemic stroke.Atherosclerosis 2006, 189:193–197.
14. Worthmann H, Tryc AB, Deb M, Goldbecker A, Ma YT, Tountopoulou A, Lichtinghagen R, Weissenborn K: Linking infection and inflammation in acute ischemic stroke.Ann N Y Acad Sci 2010, 1207:116–122.
15. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M: Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function.Trends Pharmacol Sci 2006, 27:402–409.
16. Veenman L, Gavish M: Peripheral-type benzodiazepine receptors: their implication in brain disease.Drug Develop Res 2000, 50:355–370.
17. 11C]PK11195 to omega 3 sites in baboons: positron emission tomography study.Eur J Pharmacol 1991, 200:347–351.
18. 11C]PK11195 and positron emission tomography in patients after ischemic stroke.Neuroreport 2000, 11:2957–2960.
19. 11C](R)-PK11195 PET study.Neuroimage 2005, 24:591–595.
20. Radlinska BA, Ghinani SA, Lyon P, Jolly D, Soucy JP, Minuk J, Schirrmacher R, Thiel A: Multimodal microglia imaging of fiber tracts in acute subcortical stroke.Ann Neurol 2009, 66:825–832.
21. 11C]PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats.J Cereb Blood Flow Metab 2007, 27:1975–1986.
22. 18 F]FDG-PET study.J Cereb Blood Flow Metab 2009, 29:1216–1225.
23. 11C-PK11195 in acute subcortical stroke.J Nucl Med 2010, 51:1404–1412.
24. 18 F]DPA-714.J Neurosci 2012, 32:5728–5736.
25. 18 F]DPA-714, a potential PET biomarker for neuroinflammation.Nucl Med Biol 2012, 39:570–578.
26. Corcia P, Tauber C, Vercoullie J, Arlicot N, Prunier C, Praline J, Nicolas G, Venel Y, Hommet C, Baulieu JL, Cottier JP, Roussel C, Kassiou M, Guilloteau D, Ribeiro MJ: Molecular imaging of microglial activation in amyotrophic lateral sclerosis.PLoS One 2012, 7:e52941.
27. Tang D, Hight MR, McKinley ET, Fu A, Buck JR, Smith RA, Tantawy MN, Peterson TE, Colvin DC, Ansari MS, Nickels M, Manning HC: Quantitative preclinical imaging of TSPO expression in glioma using N, N-diethyl-2-(2-(4-(2–18 F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide.J Nucl Med 2012, 53:287–294.
28. James ML, Fulton RR, Vercoullie J, Henderson DJ, Garreau L, Chalon S, Dolle F, Costa B, Guilloteau D, Kassiou M: DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization.J Nucl Med 2008, 49:814–822.
29. 11C]PK1195.Neurology 2000, 55:1052–1054.
30. Price CJ, Wang D, Menon DK, Guadagno JV, Cleij M, Fryer T, Aigbirhio F, Baron JC, Warburton EA: Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke.Stroke 2006, 37:1749–1753.
31. Nighoghossian N, Wiart M, Cakmak S, Berthezène Y, Derex L, Cho TH, Nemoz C, Chapuis F, Tisserand GL, Pialat JB, Trouillas P, Froment JC, Hermier M: Inflammatory response after ischemic stroke: a USPIO-enhanced MRI study in patients.Stroke 2007, 38:303–307.
32. 11C]vinpocetine.Curr Radiopharm 2012, 5:19–28.
33. 11C]vinpocetine.J Neurol Sci 2012, 320:110–117.
34. 11C]PK11195 in a model of cerebral ischemia in rats.PLoS One 2013, 8:e56441.
35. Feeney DM, Baron JC: Diaschisis.Stroke 1986, 17:817–830.
36. 18 F]DPA-714 in a rat model of focal cerebral ischemia.J Cereb Blood Flow Metab 2010, 30:230–241.
37. Gavish M, Bachman I, Shoukrun R, Katz Y, Veenman L, Weisinger G, Weizman A: Enigma of the peripheral benzodiazepine receptor.Pharmacol Rev 1999, 51:629–650.
38. 11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: implications for positron emission tomographic imaging of this inflammation biomarker.Neuroimage 2010, 49:2924–2932.
39. Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, Rhodes C, Pulford DJ, Bennacef I, Parker CA, StJean PL, Cardon LR, Mooser VE, Matthews PM, Rabiner EA, Rubio JP: An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28.J Cereb Blood Flow Metab 2012, 32:1–5.
40. Owen DR, Gunn RN, Rabiner EA, Bennacef I, Fujita M, Kreisl WC, Innis RB, Pike VW, Reynolds R, Matthews PM, Parker CA: Mixed-affinity binding in humans with 18-kDa translocator protein ligands.J Nucl Med 2011, 52:24–32.